Home/Filings/4/0001140361-22-021673
4//SEC Filing

Brown Spencer D. 4

Accession 0001140361-22-021673

CIK 0001472091other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 8:20 AM ET

Size

5.5 KB

Accession

0001140361-22-021673

Insider Transaction Report

Form 4
Period: 2022-06-02
Brown Spencer D.
Senior VP, General Counsel
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-06-02+150,000150,000 total
    Exercise: $4.22Exp: 2032-06-02Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on June 2, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.

Issuer

PDS Biotechnology Corp

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0001930908

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 8:20 AM ET
Size
5.5 KB